Sexual Health Sexual Health Society
Publishing on sexual health from the widest perspective
EDITORIAL

Condom use around the globe: how can we fulfil the prevention potential of male condoms?

Lee Warner A C , Maria F. Gallo A and Maurizio Macaluso B

A National Center for Chronic Disease Prevention and Health Promotion, Division of Reproductive Health, Centers for Disease Control and Prevention (CDC), Atlanta, GA 30341 USA.

B Cincinnati Children’s Hospital Medical Center, Cincinnati, OH 45229, USA.

C Corresponding author. Email: dlw7@cdc.gov

Sexual Health 9(1) 4-9 http://dx.doi.org/10.1071/SH11072
Submitted: 13 May 2011  Accepted: 19 September 2011   Published: 17 February 2012

Abstract

Despite a global epidemic of sexually transmissible infections and the availability and endorsement of condoms as an effective intervention, the overall use of condoms remains low. This review explores various challenges and opportunities to fully realizing the prevention potential for condoms.


References

[1]  UNAIDS. Global report: UNAIDS report on the global AIDS epidemic 2010. Geneva: Joint United Nations Programme on HIV/AIDS; 2010. Available online at: www.unaids.org/documents/20101123_GlobalReport_em.pdf [verified March 2011].

[2]  Gerbase AC, Rowley JT, Heymann DH, Berkley SF, Piot P. Global prevalence and incidence estimates of selected curable STDs. Sex Transm Infect 1998; 74 S12–6. open url image1

[3]  Ezzati M, Lopez AD, Rodgers A, Vander Hoorn S. Murray CJL and the Comparative Risk Assessment Collaborating Group*. Selected major risk factors and global and regional burden of disease. Lancet 2002; 360 1347–60.
Murray CJL and the Comparative Risk Assessment Collaborating Group*. Selected major risk factors and global and regional burden of disease.CrossRef | open url image1

[4]  Collier A. The humble little condom: a history. Amherst, NY: Prometheus Books; 2007.

[5]  Allen P. Condom: one small item, one giant impact. Oxford: New Internationalist Ltd.; 2007.

[6]  Halperin DT, Steiner MJ, Cassell MM, Green EC, Hearst N, Kirby D, et al The time has come for common ground on preventing sexual transmission of HIV. Lancet 2004; 364 1913–5.
The time has come for common ground on preventing sexual transmission of HIV.CrossRef | open url image1

[7]  UNAIDS. Condoms and HIV prevention: position statement by UNAIDS, UNFPA and WHO. Geneva: UNAIDS; 2009. Available online at: www.unaids.org/en/resources/presscentre/featurestories/2009/march/20090319preventionposition/ [verified March 2011].

[8]  United Nations Population Fund (UNFPA). Donor support for contraceptives and condoms for STI/HIV prevention. New York: UNFPA; 2008.

[9]  UNAIDS. Making condoms work for HIV prevention: cutting-edge perspectives. Geneva: UNAIDS; 2004.

[10]  Workowski KA, Berman SM, Centers for Disease Control and Prevention (CDC) Sexually transmitted diseases treatment guidelines. MMWR Morb Mortal Wkly Rep 2010; 59 1–110. open url image1

[11]  Carey RF, Lytle CD, Cyr WH. Implications of laboratory tests of condom integrity. Sex Transm Dis 1999; 26 216–20.
Implications of laboratory tests of condom integrity.CrossRef | 1:STN:280:DyaK1M3ktVWiuw%3D%3D&md5=008c5205cd6afbc838cc06e983674ce9CAS | open url image1

[12]  Carey RF, Herman WA, Retta SM, Rinaldi JE, Herman BA, Athey TW. Effectiveness of latex condoms as a barrier to human immunodeficiency virus-sized particles under conditions of simulated use. Sex Transm Dis 1992; 19 230–4.
Effectiveness of latex condoms as a barrier to human immunodeficiency virus-sized particles under conditions of simulated use.CrossRef | 1:STN:280:DyaK3s%2FjtFWiuw%3D%3D&md5=275d6ffa269512559095650f5992cb2aCAS | open url image1

[13]  Van de Perre P, Jacobs D, Sprecher-Goldberger S. The latex condom, an efficient barrier against sexual transmission of AIDS-related viruses. AIDS 1987; 1 49–52.
| 1:STN:280:DyaL1c7gslSntA%3D%3D&md5=5cfb0bb2728860c70004de98b346e0ccCAS | open url image1

[14]  Rietmeijer CA, Krebs JW, Feorino PM, Judson FN. Condoms as physical and chemical barriers against human immunodeficiency virus. JAMA 1988; 259 1851–3.
Condoms as physical and chemical barriers against human immunodeficiency virus.CrossRef | 1:STN:280:DyaL1c7ktFGmsA%3D%3D&md5=bd58441d212c13393245cccd6c4f848bCAS | open url image1

[15]  Cates W. The NIH condom report: the glass is 90% full. Fam Plann Perspect 2001; 33 231–3.
The NIH condom report: the glass is 90% full.CrossRef | open url image1

[16]  Boonstra H. Public health advocates say campaign to disparage condoms threatens STD prevention efforts. Guttmacher Rep Public Policy 2003; 6 1–3. open url image1

[17]  Gilden D. Condom effectiveness, reviewed, revised, reduxed. New York: Community HIV/AIDS Mobilization Project (CHAMP) HHS Watch; 2005. Available online at: http://www.champnetwork.org/media/HHSWatch0705.pdf [verified March 2011].

[18]  Warner L, Stone KM, Macaluso M, Buehler JW, Austin HD. Condom use and risk of gonorrhea and chlamydia: a systematic review of design and measurement factors assessed in epidemiologic studies. Sex Transm Dis 2006; 33 36–51.
Condom use and risk of gonorrhea and chlamydia: a systematic review of design and measurement factors assessed in epidemiologic studies.CrossRef | open url image1

[19]  Crosby RA, Bounse S. Condom effectiveness: where are we now? Sex Health 2012; 9 10–17. open url image1

[20]  Crosby R, DiClemente RJ, Holtgrave DR, Wingood GM. Design, measurement, and analytical considerations for testing hypotheses relative to condom effectiveness against non-viral STIs. Sex Transm Infect 2002; 78 228–31.
Design, measurement, and analytical considerations for testing hypotheses relative to condom effectiveness against non-viral STIs.CrossRef | 1:STN:280:DC%2BD38vjvFehtQ%3D%3D&md5=309ffc63b433761a654aee6878d11949CAS | open url image1

[21]  Steiner MJ, Feldblum PJ, Padian N. Invited commentary: condom effectiveness – will prostate-specific antigen shed new light on this perplexing problem? Am J Epidemiol 2003; 157 298–300.
Invited commentary: condom effectiveness – will prostate-specific antigen shed new light on this perplexing problem?CrossRef | open url image1

[22]  Taylor D. Issues in the design, analysis and interpretation of condom functionality studies. Contraception 2009; 80 237–44.
Issues in the design, analysis and interpretation of condom functionality studies.CrossRef | open url image1

[23]  Noar SM, Cole C, Carlyle K. Condom use measurement in 56 studies of sexual risk behavior: review and recommendations. Arch Sex Behav 2006; 35 327–45.
Condom use measurement in 56 studies of sexual risk behavior: review and recommendations.CrossRef | open url image1

[24]  Sanders SA, Yarber WL, Kaufman EL, Crosby RA, Graham CA, Milhausen RR. Condom use errors and problems: a global view. Sex Health 2012; 9 81–95. open url image1

[25]  Lagakos SW, Gable AR (editors). Methodological challenges in biomedical HIV prevention trials. Washington DC: National Academies Press; 2008.

[26]  National Institute of Allergy and Infectious Diseases (NIAID). Workshop summary: scientific evidence on condom effectiveness for sexually transmitted disease (STD) prevention. Bethesda, MD: NIAID; 2001.

[27]  Weller S, Davis K. Condom effectiveness in reducing heterosexual HIV transmission. Cochrane Database Syst Rev 2002; CD003255
| 1:STN:280:DC%2BD383ksl2msw%3D%3D&md5=f17e26fc8b90a47e28618fb1e64e60ebCAS | open url image1

[28]  Holmes KK, Levine R, Weaver M. Effectiveness of condoms in preventing sexually transmitted infections. Bull World Health Organ 2004; 82 454–61. open url image1

[29]  Koss CA, Dunne EF, Warner L. A systematic review of epidemiologic studies assessing condom use and risk of syphilis. Sex Transm Dis 2009; 36 401–5.
A systematic review of epidemiologic studies assessing condom use and risk of syphilis.CrossRef | open url image1

[30]  Martin ET, Krantz E, Gottlieb SL, Magaret AS, Langenberg A, Stanberry L, et al A pooled analysis of the effect of condoms in preventing HSV-2 acquisition. Arch Intern Med 2009; 169 1233–40.
A pooled analysis of the effect of condoms in preventing HSV-2 acquisition.CrossRef | open url image1

[31]  Wald A, Langenberg AG, Krantz E, Douglas JM, Handsfield HH, DiCarlo RP, et al The relationship between condom use and herpes simplex virus acquisition. Ann Intern Med 2005; 143 707–13. open url image1

[32]  Winer RL, Hughes JP, Feng Q, O’Reilly S, Kiviat NB, Holmes KK, et al Condom use and the risk of genital human papillomavirus infection in young women. N Engl J Med 2006; 354 2645–54.
Condom use and the risk of genital human papillomavirus infection in young women.CrossRef | 1:CAS:528:DC%2BD28XmtFSgtLo%3D&md5=29d6e35802dc767bbad2a5dc568b0cd1CAS | open url image1

[33]  Warner L, Newman D, Peterman T, Kamb M, Douglas JM, Zenilman J, et al Condom effectiveness for reducing transmission of gonorrhea and chlamydia: the importance of assessing partner infection status. Am J Epidemiol 2004; 159 242–51.
Condom effectiveness for reducing transmission of gonorrhea and chlamydia: the importance of assessing partner infection status.CrossRef | open url image1

[34]  Warner L, Macaluso M, Austin HD, Kleinbaum DK, Artz L, Fleenor ME, et al Application of the case-crossover design to reduce unmeasured confounding in studies of condom effectiveness. Am J Epidemiol 2005; 161 765–73.
Application of the case-crossover design to reduce unmeasured confounding in studies of condom effectiveness.CrossRef | open url image1

[35]  Macaluso M, Blackwell R, Jamieson DJ, Kulczycki A, Chen MP, Akers R, et al Efficacy of the male latex condom and of the female polyurethane condom as barriers to semen during intercourse: a randomized clinical trial. Am J Epidemiol 2007; 166 88–96.
Efficacy of the male latex condom and of the female polyurethane condom as barriers to semen during intercourse: a randomized clinical trial.CrossRef | open url image1

[36]  Crosby R, Warner L. Pending research issues in male condom use promotion. Sex Health 2008; 5 317–9.
Pending research issues in male condom use promotion.CrossRef | open url image1

[37]  Mauck CK, Doncel GF. Biomarkers of semen in the vagina: applications in clinical trials of contraception and prevention of sexually transmitted pathogens including HIV. Contraception 2007; 75 407–19.
Biomarkers of semen in the vagina: applications in clinical trials of contraception and prevention of sexually transmitted pathogens including HIV.CrossRef | 1:CAS:528:DC%2BD2sXls1aisrc%3D&md5=f491f804d2232c713529ff1212285fcbCAS | open url image1

[38]  Duerr A, Gallo MF, Warner L, Jamieson DJ, Kulczycki A, Macaluso M. Measures of male condom failure and incorrect use. Sex Transm Dis 2011; open url image1

[39]  Crosby R, DiClemente RJ, Charnigo R, Snow G, Troutman A. A brief, clinic-based, safer sex intervention for heterosexual African American men newly diagnosed with an STD: a randomized controlled trial. Am J Public Health 2009; 99 S96–103.
A brief, clinic-based, safer sex intervention for heterosexual African American men newly diagnosed with an STD: a randomized controlled trial.CrossRef | open url image1

[40]  Keiser NH. Strategies of media marketing for “America Responds to AIDS” and applying lessons learned. Public Health Rep 1991; 106 623–7.
| 1:STN:280:DyaK38%2Fms1OjsQ%3D%3D&md5=9e93869b4b593f80a3a71c44f39ced8dCAS | open url image1

[41]  Centers for Disease Control and Prevention (CDC) Evolution of HIV/AIDS prevention programs – United States, 1981–2006. MMWR Morb Mortal Wkly Rep 2006; 55 597–603. open url image1

[42]  Pazol K, Warner L, Gavin L, Callaghan WM, Spitz AM, Anderson JE, et al Teen pregnancy – United States, 1991–2009. MMWR Morb Mortal Wkly Rep 2011; 60 414–20. open url image1

[43]  Fortenberry JD, Schick V, Herbenick D, Sanders SA, Dodge B, Reece M. Sexual behaviors and condom use at last vaginal intercourse: a national sample of adolescents ages 14 to 17 years. J Sex Med 2010; 7 305–14.
Sexual behaviors and condom use at last vaginal intercourse: a national sample of adolescents ages 14 to 17 years.CrossRef | open url image1

[44]  Anderson J, Warner L, Macaluso M. Condom use among U.S. adults at last sexual intercourse, 1996–2008: an update from national survey data. Sex Transm Dis 2011; 38 919–21. open url image1

[45]  Sanders SA, Reece M, Herbenick D, Schick V, Dodge B, Fortenberry JD. Condom use during most recent vaginal intercourse event among a probability sample of adults in the United States. J Sex Med 2010; 7 362–73.
Condom use during most recent vaginal intercourse event among a probability sample of adults in the United States.CrossRef | open url image1

[46]  Godeau E, Gabhainn SN, Vignes C, Ross J, Boyce W, Todd J. Contraceptive use by 15-year-old students at their last sexual intercourse: results from 24 countries. Arch Pediatr Adolesc Med 2008; 162 66–73.
Contraceptive use by 15-year-old students at their last sexual intercourse: results from 24 countries.CrossRef | open url image1

[47]  Johnson AM, Mercer CH, Erens B, Copas AJ, McManus S, Wellings K, et al Sexual behaviour in Britain: partnership, practices, and HIV risk behaviours. Lancet 2001; 358 1835–42.
Sexual behaviour in Britain: partnership, practices, and HIV risk behaviours.CrossRef | 1:STN:280:DC%2BD3MjgtVCmtw%3D%3D&md5=67fb9695b7634672e4bbfc7e25710742CAS | open url image1

[48]  Adair T. Men’s condom use in higher-risk sex: trends and determinants in five sub-Saharan countries. DHS Working Paper 2008; 34: 1–29.

[49]  Padian NS, van der Straten A, Ramjee G, Chipato T, de Bruyn G, Blanchard K, et al Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomised controlled trial. Lancet 2007; 370 251–61.
Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomised controlled trial.CrossRef | open url image1

[50]  Skoler-Karpoff S, Ramjee G, Ahmed K, Altini L, Plagianos MG, Friedland B, et al Efficacy of Carraguard for prevention of HIV infection in women in South Africa: a randomised, double-blind, placebo-controlled trial. Lancet 2008; 372 1977–87.
Efficacy of Carraguard for prevention of HIV infection in women in South Africa: a randomised, double-blind, placebo-controlled trial.CrossRef | 1:CAS:528:DC%2BD1cXhsVKlsLvN&md5=72e45aa11111c0ef639531dfad118311CAS | open url image1

[51]  Van Damme L, Govinden R, Mirembe FM, Guédou F, Solomon S, Becker ML, et al Lack of effectiveness of cellulose sulfate gel for the prevention of vaginal HIV transmission. N Engl J Med 2008; 359 463–72.
Lack of effectiveness of cellulose sulfate gel for the prevention of vaginal HIV transmission.CrossRef | 1:CAS:528:DC%2BD1cXpt1Shu7c%3D&md5=be96630e8368ad33bb5491f57a86d963CAS | open url image1

[52]  McCormack S, Ramjee G, Kamali A, Rees H, Crook AM, Gafos M, et al PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trial. Lancet 2010; 376 1329–37.
PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trial.CrossRef | 1:CAS:528:DC%2BC3cXht12ks7nN&md5=1cf270eb1d7aab95e9b5ab91cb8d1cbbCAS | open url image1

[53]  Abdool Karim Q, Abdool Karim SS, Frohlich JA, Grobler AC, Baxter C, Mansoor LE, et al Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science 2010; 329 1168–74.
Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women.CrossRef | 1:CAS:528:DC%2BC3cXhtV2hsr%2FI&md5=8285ce242cb3cffcd596b459dfca99e7CAS | open url image1

[54]  Abdool Karim SS, Richardson BA, Ramjee G, Hoffman IF, Chirenje ZM, Taha T, et al Safety and effectiveness of BufferGel and 0.5% PRO2000 gel for the prevention of HIV infection in women. AIDS 2011; [Epub ahead of print.]
Safety and effectiveness of BufferGel and 0.5% PRO2000 gel for the prevention of HIV infection in women.CrossRef | open url image1

[55]  Warner L, Newman DR, Kamb ML, Fishbein M, Douglas JM, Zenilman J, et al Problems with condom use among patients attending sexually transmitted disease clinics: prevalence, predictors, and relation to incident gonorrhea and chlamydia. Am J Epidemiol 2008; 167 341–9.
Problems with condom use among patients attending sexually transmitted disease clinics: prevalence, predictors, and relation to incident gonorrhea and chlamydia.CrossRef | open url image1

[56]  Crosby RA, Yarber WL, Graham CA, Sanders SA. Does it fit okay? Problems with condom use as a function of self-reported poor fit. Sex Transm Infect 2010; 86 36–8.
Does it fit okay? Problems with condom use as a function of self-reported poor fit.CrossRef | 1:STN:280:DC%2BC3c7gvVymtg%3D%3D&md5=cf3096a45e3f87c84e4f1e36d7b02156CAS | open url image1

[57]  Khan SI, Hudson-Rodd N, Saggers S, Bhuiyan MI, Bhuiya A. Safer sex or pleasurable sex? Rethinking condom use in the AIDS era. Sex Health 2004; 1 217–25.
Safer sex or pleasurable sex? Rethinking condom use in the AIDS era.CrossRef | open url image1

[58]  Graham CA, Crosby R, Yarber WL, Sanders SA, McBride K, Milhausen RR, et al Erection loss in association with condom use among young men attending a public STI clinic: potential correlates and implications for risk behaviour. Sex Health 2006; 3 255–60.
Erection loss in association with condom use among young men attending a public STI clinic: potential correlates and implications for risk behaviour.CrossRef | open url image1

[59]  Warner L, Clay-Warner J, Boles J, Williamson J. Assessing condom use practices. Implications for evaluating method and user effectiveness. Sex Transm Dis 1998; 25 273–7.
Assessing condom use practices. Implications for evaluating method and user effectiveness.CrossRef | 1:STN:280:DyaK1czislalsw%3D%3D&md5=903ea8278fd7489092047079f1e30d71CAS | open url image1

[60]  Paz-Bailey G, Koumans EH, Sternberg M, Pierce A, Papp J, Unger ER, et al The effect of correct and consistent condom use on chlamydial and gonococcal infection among urban adolescents. Arch Pediatr Adolesc Med 2005; 159 536–42.
The effect of correct and consistent condom use on chlamydial and gonococcal infection among urban adolescents.CrossRef | open url image1

[61]  Calzavara L, Burchell AN, Remis RS, Major C, Corey P, Myers T, et al Delayed application of condoms is a risk factor for human immunodeficiency virus infection among homosexual and bisexual men. Am J Epidemiol 2003; 157 210–7.
Delayed application of condoms is a risk factor for human immunodeficiency virus infection among homosexual and bisexual men.CrossRef | open url image1

[62]  Hatherall B, Ingham R, Stone N, McEachran J. How, not just if, condoms are used: the timing of condom application and removal during vaginal sex among young people in England. Sex Transm Infect 2007; 83 68–70.
How, not just if, condoms are used: the timing of condom application and removal during vaginal sex among young people in England.CrossRef | 1:STN:280:DC%2BD2s%2FnvVeqsA%3D%3D&md5=376772be73946cdf171ad3270c78e127CAS | open url image1

[63]  Hensel DJ, Stupiansky NW, Herbenick D, Dodge B, Reece M. When condom use is not condom use: an event-level analysis of condom use behaviors during vaginal intercourse. J Sex Med 2011; 8 28–34.
When condom use is not condom use: an event-level analysis of condom use behaviors during vaginal intercourse.CrossRef | open url image1

[64]  Albert AE, Warner DL, Hatcher RA, Trussell J, Bennett C. Condom use among female commercial sex workers in Nevada’s legal brothels. Am J Public Health 1995; 85 1514–20.
Condom use among female commercial sex workers in Nevada’s legal brothels.CrossRef | 1:STN:280:DyaK28%2Fjs1Grsg%3D%3D&md5=bff775537cb41f1ccc03bfbc65a55134CAS | open url image1

[65]  Macaluso M, Kelaghan J, Artz L, Austin H, Fleenor M, Hook EW, et al Mechanical failure of the latex condom in a cohort of women at high STD risk. Sex Transm Dis 1999; 26 450–8.
Mechanical failure of the latex condom in a cohort of women at high STD risk.CrossRef | 1:STN:280:DyaK1MvitlWhtQ%3D%3D&md5=a4c74bc1a117ed2318dfb24b98093ad2CAS | open url image1

[66]  Spruyt A, Steiner MJ, Joanis C, Glover LH, Piedrahita C, Alvarado G, et al Identifying condom users at risk for breakage and slippage: findings from three international sites. Am J Public Health 1998; 88 239–44.
Identifying condom users at risk for breakage and slippage: findings from three international sites.CrossRef | 1:STN:280:DyaK1c7ltFOitg%3D%3D&md5=cacf2c979696cb07fc94673475d47d36CAS | open url image1

[67]  Steiner M, Piedrahita C, Glover L, Joanis C. Can condom users likely to experience condom failure be identified? Fam Plann Perspect 1993; 25 220–3, 226.
Can condom users likely to experience condom failure be identified?CrossRef | 1:STN:280:DyaK2c%2FosFGgtA%3D%3D&md5=55ba74202ac334f554116987df4e2373CAS | open url image1

[68]  Cecil M, Nelson A, Trussell J, Hatcher R. If the condom doesn’t fit, you must resize it. Contraception 2010; 82 489–90.
If the condom doesn’t fit, you must resize it.CrossRef | open url image1

[69]  Trussell J, Warner DL, Hatcher RA. Condom slippage and breakage rates. Fam Plann Perspect 1992; 24 20–3.
Condom slippage and breakage rates.CrossRef | 1:STN:280:DyaK383ovF2rug%3D%3D&md5=6d2876be2cff124787f359d62f1fd3afCAS | open url image1

[70]  Cook L, Nanda K, Taylor D. Randomized crossover trial comparing the eZ. on plastic condom and a latex condom. Contraception 2001; 63 25–31.
Randomized crossover trial comparing the eZ. on plastic condom and a latex condom.CrossRef | 1:STN:280:DC%2BD3M3ntVaitQ%3D%3D&md5=9e7c7d835758323c2a3606f4f3a475c9CAS | open url image1

[71]  Gallo MF, Grimes DA, Lopez LM, Schulz KF. Non-latex versus latex male condoms for contraception. Cochrane Database Syst Rev 2006; 1 CD003550 open url image1

[72]  Gallo M, Kilbourne-Brook M, Coffey PS. A review of the effectiveness and acceptability of the female condom for dual protection. Sex Health 2011; 9 18–26. open url image1

[73]  Anonymous. Condoms: a global strategic business report. San Jose: Global Industry Analysts Inc.; 2008.

[74]  Macaluso M, Demand MJ, Artz LM, Hook EW. Partner type and condom use. AIDS 2000; 14 537–46.
Partner type and condom use.CrossRef | 1:STN:280:DC%2BD3c3ktFKhug%3D%3D&md5=35a03628a3d5714892d6841b6496a5e0CAS | open url image1

[75]  United Nations Population Fund (UNPFA). State of world population 2005. The promise of equality, gender equity, reproductive health and the millennium development goals. New York: UNPF; 2005.

[76]  Marston C, King E. Factors that shape young people’s sexual behaviour: a systematic review. Lancet 2006; 368 1581–6.
Factors that shape young people’s sexual behaviour: a systematic review.CrossRef | open url image1

[77]  Corbett AM, Dickson-Gómez J, Hilario H, Weeks MR. A little thing called love: condom use in high-risk primary heterosexual relationships. Perspect Sex Reprod Health 2009; 41 218–24.
A little thing called love: condom use in high-risk primary heterosexual relationships.CrossRef | open url image1

[78]  Thomsen S, Stalker M, Toroitich-Ruto C. Fifty ways to leave your rubber: how men in Mombasa rationalise unsafe sex. Sex Transm Infect 2004; 80 430–4.
Fifty ways to leave your rubber: how men in Mombasa rationalise unsafe sex.CrossRef | 1:STN:280:DC%2BD2crpvFGltA%3D%3D&md5=3b530affb682419b0857ff4a03251cbeCAS | open url image1

[79]  Higgins JA, Hoffman S, Graham CA, Sanders SA. Relationships between condoms, hormonal methods, and sexual pleasure and satisfaction: an exploratory analysis from the Women’s Well-Being and Sexuality Study. Sex Health 2008; 5 321–30.
Relationships between condoms, hormonal methods, and sexual pleasure and satisfaction: an exploratory analysis from the Women’s Well-Being and Sexuality Study.CrossRef | open url image1

[80]  Philpott A, Knerr W, Maher D. Promoting protection and pleasure: amplifying the effectiveness of barriers against sexually transmitted infections and pregnancy. Lancet 2006; 368 2028–31.
Promoting protection and pleasure: amplifying the effectiveness of barriers against sexually transmitted infections and pregnancy.CrossRef | open url image1

[81]  Randolph ME, Pinkerton SD, Bogart LM, Cecil H, Abramson PR. Sexual pleasure and condom use. Arch Sex Behav 2007; 36 844–8.
Sexual pleasure and condom use.CrossRef | open url image1

[82]  Charania MR, Crepaz N, Guenther-Gray G, Henny K, Liau A, Willis LA, et al Efficacy of structural-level condom distribution interventions: a meta-analysis of U.S. and international studies, 1998. AIDS Behav 2011; 15 1283–97. open url image1

[83]  UNAIDS. Condom social marketing: selected case studies. Geneva: UNAIDS; 2000.

[84]  Okie S. Fighting HIV – lessons from Brazil. N Engl J Med 2006; 354 1977–81.
Fighting HIV – lessons from Brazil.CrossRef | 1:CAS:528:DC%2BD28XksFGhs74%3D&md5=72c71d454deb870c9104ab07e73358d2CAS | open url image1

[85]  Singh S, Darroch JE, Bankole A. A, B and C in Uganda: the roles of abstinence, monogamy and condom use in HIV decline. Reprod Health Matters 2004; 12 129–35.
A, B and C in Uganda: the roles of abstinence, monogamy and condom use in HIV decline.CrossRef | open url image1

[86]  Sun X, Lu F, Wu Z, Poundstone K, Zeng G, Xu P, et al Evolution of information-driven HIV/AIDS policies in China. Int J Epidemiol 2010; 39 ii4–13.
Evolution of information-driven HIV/AIDS policies in China.CrossRef | open url image1


Full Text PDF (211 KB) Export Citation